Sichuan Hebang Biotechnology Corporation Limited (603077.SS) SHH

Currency In CNY

AD

Valuation

Market Cap18.04B
Enterprise Value20.05B
P/E Ratio-44.59
PEG Ratio-0.01
Price/Sales Ratio2.45
Price/Book Ratio0.93
Enterprise/Revenue2.78
Enterprise/EBITDA44.69

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.05
Operating Margin-0.04
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.02

Income Statement

Revenue7.18B
Revenue/Share0.86
Gross Profit671.57M
EBITDA506.89M
Net Income-536.41M
Diluted EPS-0.07

Balance Sheet

Total Cash6.82B
Total Cash/Share0.85
Total Debt9.07B
Total Debt/Equity0.5
Current Ratio3.85
Book Value Per Share2.27

Price History

52-Week Change16.02
52-Week High3.54
52-Week Low1.76
Moving Average 50 Days2.52
Moving Average 200 Days2.5

Statistics

Average Volume201.03M
Shares Outstanding8B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.28
Last Split Factor11:5
Last Split DateJuly 05, 2017
AD